ONEVIEW HEALTHCARE PLC (ONE)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

ONE - ONEVIEW HEALTHCARE PLC

FNArena Sector : Medical Equipment & Devices
Year End: December
GICS Industry Group : Health Care Equipment & Services
Debt/EBITDA: -0.12
Index:

LAST PRICE CHANGE +/- CHANGE % VOLUME

$0.30

20 Dec
2024

0.000

OPEN

$0.30

0.000

HIGH

$0.30

104,273

LOW

$0.30

TARGET
$0.40 33.3% upside
OTHER COMPANIES IN THE SAME SECTOR
4DX . AT1 . AYA . BB1 . BRN . CAT . CBL . CGS . CMP . COH . CSX . CU6 . CVB . CYC . EBR . EMV . EYE . FPH . IDX . IME . IMR . IPD . LDX . MX1 . NAN . PCK . PEB . PGC . PME . RMD . SOM . TRJ . UBI . VTI .
FNARENA'S MARKET CONSENSUS FORECASTS
ONE: 1
Title FY24
Forecast		 FY25
Forecast
EPS (cps) N/A xxx
DPS (cps) N/A xxx
EPS Growth N/A xxx
DPS Growth N/A xxx
PE Ratio N/A xxx
Dividend Yield 0.0% xxx
Div Pay Ratio(%) N/A xxx
This company reports in EUR.
All estimates have been converted into AUD by FNArena at present FX values.

Dividend yield today if purchased 3 years ago: N/A

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

 N/A

Estimated Dividend Growth
(Average Of Past Three Years)

  %

Amount Invested

 $ 

Tell Me The Dividend After This Many Years
Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2024 FactSet UK Limited. All rights reserved
Title 201820192020202120222023
EPS Basic xxxxxxxxxxxxxxx-2.5
DPS All xxxxxxxxxxxxxxx0.0
Sales/Revenue xxxxxxxxxxxxxxx15.3 M
Book Value Per Share xxxxxxxxxxxxxxx2.2
Net Operating Cash Flow xxxxxxxxxxxxxxx-11.8 M
Net Profit Margin xxxxxxxxxxxxxxx-95.08 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201820192020202120222023
Return on Capital Employed xxxxxxxxxxxxxxx-158.63 %
Return on Invested Capital xxxxxxxxxxxxxxx-144.10 %
Return on Assets xxxxxxxxxxxxxxx-52.39 %
Return on Equity xxxxxxxxxxxxxxx-158.63 %
Return on Total Capital xxxxxxxxxxxxxxx-130.56 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx-12.0 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201820192020202120222023
Short-Term Debt xxxxxxxxxxxxxxx0 M
Long Term Debt xxxxxxxxxxxxxxx1 M
Total Debt xxxxxxxxxxxxxxx2 M
Goodwill - Gross xxxxxxxxxxxxxxx-
Cash & Equivalents - Generic xxxxxxxxxxxxxxx19 M
Price To Book Value xxxxxxxxxxxxxxx10.85

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201820192020202120222023
Capex xxxxxxxxxxxxxxx0.8 M
Capex % of Sales xxxxxxxxxxxxxxx5.55 %
Cost of Goods Sold xxxxxxxxxxxxxxx6 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx23 M
Research & Development xxxxxxxxxxxxxxx13 M
Investments - Total xxxxxxxxxxxxxxx0 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

1.0

No. Of Recommendations

1
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Bell Potter

29/11/2024

1

Initiation of coverage with

$0.40

33.33%

Bell Potter initiates coverage on Oneview Healthcare which owns the fully automated, integrated and personalised Care Experience Platform, helping streamline nursing workflows and aiding safe and timely hospital discharges.

This technology connects patients, families and care teams with services, education and information, to deliver 'one view' of the patient environment, during hospital stays, explain the analysts.

Already, the platform is contracted in over 110 hospitals from 24 health systems, and installed in three of the top twenty hospitals in the US, observes the broker, resulting in 10,361 live beds out of 18,313 contracted beds.

By FY27, Bell Potter believes Oneview Healthcare can reach the cash flow breakeven point of around 23,000 average live beds.

The broker begins with a Speculative Buy rating and 40c target.

FORECAST
Bell Potter forecasts a full year FY25 dividend of 0.70 cents and EPS of minus -1.50 cents.
Access Stockbroker Research History >
EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

0

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY
Access Extra Coverage Research History >

ONE STOCK CHART

FNArena News on ONE

1
Health Is Wealth

Jul 27 2022 - Australia
2
ASX Companies Adopt ESG Global Reporting Tool

Jun 01 2021 - FYI
3
Telehealth: Part Of Healthcare Revolution

May 12 2021 - Australia
4
FNArena Corporate Results Monitor

Mar 01 2019 - Australia
5
FNArena Corporate Results Monitor

Aug 30 2018 - Australia

Latest Medical Equipment & Devices News

1
Diagnostic Imaging Radiates Opportunity

Dec 18 2024 - Small Caps
2
ResMed’s Bounce-Back Complete

Oct 29 2024 - Australia
3
Dr Boreham’s Crucible: Pro Medicus

Sep 04 2024 - Australia
4
Pro Medicus: Don’t Stop Me Now

Aug 20 2024 - Technicals
5
Dr Boreham’s Crucible: Blinklab

May 20 2024 - Small Caps
6
ResMed Silences The Doubters

Apr 29 2024 - Australia
7
Dr Boreham’s Crucible: 4D Medical

Apr 23 2024 - Small Caps
8
Uptrend Resumed For ResMed

Mar 19 2024 - Technicals
9
Dr Boreham’s Crucible: Cochlear

Feb 28 2024 - Australia
10
Rudi Interviewed: Ongoing Potential In Technology & Growth

Feb 19 2024 - Rudi's View